Hengtong(SH:600226)2022-04-27 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥158,545,781.18, representing a year-on-year increase of 2.50%[6] - The net profit attributable to shareholders of the listed company reached ¥333,681,327.24, a significant increase of 210.23% compared to the same period last year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥22,259,241.28, reflecting a decrease of 75.98% year-on-year[6] - Basic and diluted earnings per share were both ¥0.11, an increase of 266.67% year-on-year[6] - The weighted average return on equity was 11.80%, an increase of 6.83 percentage points compared to the previous year[6] - Total operating revenue for Q1 2022 was RMB 158,545,781.18, an increase of 2.8% compared to RMB 154,686,061.60 in Q1 2021[29] - Net profit for Q1 2022 reached RMB 333,682,227.24, compared to RMB 107,540,372.20 in Q1 2021, representing a significant increase of 210.5%[33] - Total comprehensive income for the period was CNY 334,709,783.46, compared to CNY 106,942,796.92 in the previous year, representing a significant increase[35] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,264,814,479.80, up 10.87% from the end of the previous year[9] - The equity attributable to shareholders of the listed company increased to ¥2,944,202,828.81, a rise of 10.71% year-on-year[9] - As of March 31, 2022, the company's total assets amounted to RMB 3,264,814,479.80, an increase from RMB 2,944,798,906.16 as of December 31, 2021[21] - Total liabilities as of the reporting date were RMB 324,995,013.49, compared to RMB 288,635,135.06 in the previous year, indicating a year-over-year increase of 12.6%[29] - Total equity attributable to shareholders was RMB 2,944,202,828.81, up from RMB 2,659,499,359.78 in the previous year, reflecting an increase of 10.7%[29] Cash Flow - The net cash flow from operating activities was negative at -¥2,931,825.92, a decline of 102.74% compared to the previous year[6] - Cash inflows from operating activities totaled CNY 98,947,045.82, a decrease of 51.49% from CNY 204,033,090.47 in the previous year[38] - The net cash flow from operating activities was negative at CNY -2,931,825.92, contrasting sharply with CNY 106,999,854.69 in the prior year[38] - Cash inflows from investment activities amounted to CNY 454,260,536.23, down from CNY 523,400,092.23, reflecting a decline of 13.23%[38] - The net cash flow from investment activities was CNY 349,202,721.31, an increase of 77.06% compared to CNY 197,285,609.50 in the previous year[38] - The net cash flow from financing activities was CNY -68,773,144.43, an improvement from CNY -125,920,222.43 in the same period last year[40] - The total cash and cash equivalents at the end of the period were CNY 628,794,853.07, compared to CNY 254,598,312.08 at the end of the previous year, showing an increase of 146.67%[40] Operational Metrics - The company reported a significant decline in the performance of its amino acid products due to market conditions, impacting the net profit attributable to shareholders after deducting non-recurring gains and losses[10] - The company's cash and cash equivalents reached RMB 648,939,722.12, up from RMB 352,996,211.31 year-over-year[21] - Total current assets increased to RMB 1,152,596,303.84 from RMB 729,712,183.70, reflecting a growth of approximately 57.8%[24] - The company's accounts receivable rose to RMB 61,617,922.03, compared to RMB 59,742,247.28 in the previous year[21] - The company's inventory decreased to RMB 57,234,720.01 from RMB 80,444,934.98, indicating a reduction of approximately 29%[21] - The company reported a significant increase in other receivables, which rose to RMB 263,566,315.83 from RMB 92,025,970.10[21] Shareholder Information - The total number of shares held by major shareholders indicates a potential change in control, with the largest shareholder holding 22.22% of shares[20] - The company has a share repurchase account holding 170,768,742 shares, representing 5.48% of the total share capital[20] - The company anticipates a change in its controlling shareholder due to the judicial disposal of shares held by a major shareholder[20] Expenses - Total operating costs for Q1 2022 were RMB 172,673,930.63, up from RMB 155,280,385.33 in Q1 2021, reflecting a year-over-year increase of 11.2%[29] - Research and development expenses for Q1 2022 were RMB 4,178,493.77, down 32.5% from RMB 6,207,303.29 in Q1 2021[29] - The company reported a decrease in tax expenses to RMB 1,388,624.66 in Q1 2022 from RMB 1,982,092.88 in Q1 2021, a reduction of 30%[29] - The company reported a decrease in cash outflows for employee payments to CNY 23,385,055.43 from CNY 28,177,323.59, a reduction of 17.73%[38] - The company experienced a decrease in cash outflows related to taxes paid, which totaled CNY 2,906,127.70, down from CNY 4,164,436.04, a decline of 30.19%[38]